Chooses industry leading Vault CRM to empower commercial teams with
\nnext-generation CRM capabilities and agentic AI<\/i><\/p>\n
\nPLEASANTON, CA \u2014 Jan. 7, 2026 \u2014<\/strong> ³Ô¹Ï±¬ÁÏ Systems<\/a> (NYSE: VEEV) today announced that Novo Nordisk\u2019s International Operations business unit has committed to use ³Ô¹Ï±¬ÁÏ Vault CRM<\/a>.<\/p>\n \n\u201cWe are honored to expand our partnership with Novo Nordisk to Vault CRM,\u201d said ³Ô¹Ï±¬ÁÏ CEO Peter Gassner. \u201cWorking together with AI-driven technology, we will do our part to help Novo Nordisk deliver breakthrough medicines to defeat serious chronic diseases and create long-term health for patients around the world.\u201d\n<\/p>\n \nVault CRM is part of the Vault CRM Suite of deep applications and agentic AI<\/a> that drive more effective commercial execution across personal and digital channels. With advanced global capabilities, Vault CRM Suite addresses the industry\u2019s unique and evolving country-specific business and compliance requirements.\n<\/p>\n \n\u201cWe are excited to expand our strategic partnership with ³Ô¹Ï±¬ÁÏ by moving to Vault CRM,\u201d said Emil Kongsh\u00f8j Larsen, executive vice president, International Operations at Novo Nordisk. \u201cVault CRM will help provide Novo Nordisk the technology foundation to help drive commercial execution.\u201d\n<\/p>\n \nFor all the latest information on ³Ô¹Ï±¬ÁÏ Vault CRM with agentic AI visit veeva.com\/eu\/CRM<\/a> and connect with ³Ô¹Ï±¬ÁÏ on LinkedIn<\/a>.\n<\/p>\n About ³Ô¹Ï±¬ÁÏ Systems<\/strong> ³Ô¹Ï±¬ÁÏ Forward-Looking Statements<\/strong>
\n³Ô¹Ï±¬ÁÏ delivers the industry cloud for life sciences with software, data, and business consulting. Committed to innovation, product excellence, and customer success, ³Ô¹Ï±¬ÁÏ serves more than 1,500 customers, ranging from the world\u2019s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation<\/a>, ³Ô¹Ï±¬ÁÏ is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com\/eu<\/a>.\n<\/p>\n
\nThis release contains forward-looking statements regarding ³Ô¹Ï±¬ÁÏ\u2019s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the period ended October 31, 2025, which you can find here<\/a> (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at sec.gov<\/a>.\n<\/p>\n